Personalis Inc. (PSNL)
NASDAQ: PSNL
· Real-Time Price · USD
6.08
-0.08 (-1.30%)
At close: Jun 25, 2025, 2:54 PM
-1.30% (1D)
| Bid | 6.07 |
| Market Cap | 537.02M |
| Revenue (ttm) | 85.69M |
| Net Income (ttm) | -84.07M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -4.71 |
| Forward PE | -6.66 |
| Analyst | Strong Buy |
| Ask | 6.1 |
| Volume | 560,614 |
| Avg. Volume (20D) | 801,862 |
| Open | 6.17 |
| Previous Close | 6.16 |
| Day's Range | 5.91 - 6.17 |
| 52-Week Range | 1.14 - 7.20 |
| Beta | 1.87 |
About PSNL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PSNL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PSNL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Personalis Inc. is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+21%
Personalis shares are trading higher after the com...
Unlock content with
Pro Subscription
6 months ago
+9.32%
Personalis shares are trading higher after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.
